HOOKIPA Pharma Q1 2024 GAAP EPS $0.11 Beats $(0.10) Estimate, Sales $36.599M Beat $2.800M Estimate
Author: Benzinga Newsdesk | May 09, 2024 07:15am
HOOKIPA Pharma (NASDAQ:
HOOK) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.10) by 210 percent. This is a 140.74 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $36.599 million which beat the analyst consensus estimate of $2.800 million by 1.21K percent. This is a 1.05K percent increase over sales of $3.176 million the same period last year.
Posted In: HOOK